Cyclacel Pharmaceuticals, Inc. (CYCCP) Financials

$4.00

$0.4 (11.11%)
Last update: 04:00 PM EST
Day's range
$4
Day's range
$4
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning201820182019201920202020202120212022202220232023202420240%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%-30000%-30000%Profit Margin
Profit Margin
Revenue
Earnings

CYCCP Income statement / Annual

Last year (2024), Cyclacel Pharmaceuticals, Inc.'s total revenue was $43,000.00, a decrease of 89.76% from the previous year. In 2024, Cyclacel Pharmaceuticals, Inc.'s net income was -$11.21 M. See Cyclacel Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $43,000.00 $420,000.00 $0.00 $0.00 $0.00 $0.00 $150,000.00 $0.00 $843,000.00 $1.94 M
Cost of Revenue $6,000.00 $0.00 $32,000.00 $43,000.00 $20,000.00 $20,000.00 $4.33 M $32,000.00 $9.48 M $12.38 M
Gross Profit $37,000.00 $420,000.00 -$32,000.00 -$43,000.00 -$20,000.00 -$20,000.00 -$4.18 M -$32,000.00 -$8.63 M -$10.44 M
Gross Profit Ratio 0.86 1 0 0 0 0 -27.85 0 -10.24 -5.37
Research and Development Expenses $6.66 M $19.16 M $20.27 M $15.48 M $4.76 M $4.66 M $4.33 M $4.24 M $9.48 M $12.38 M
General & Administrative Expenses $5.39 M $6.72 M $7.38 M $7.46 M $5.88 M $5.02 M $5.37 M $5.25 M $5.52 M $5.73 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20,000.00
Selling, General & Administrative Expenses $5.39 M $6.72 M $7.38 M $7.46 M $5.88 M $5.02 M $5.37 M $5.25 M $5.52 M $5.75 M
Other Expenses $0.00 $0.00 $1.30 M $144,000.00 $891,000.00 $231,000.00 $682,000.00 $949,000.00 $0.00 $12,132.00
Operating Expenses $12.05 M $25.87 M $27.66 M $22.94 M $10.64 M $9.68 M $9.70 M $9.49 M $14.99 M $18.13 M
Cost And Expenses $12.05 M $25.87 M $27.66 M $22.94 M $10.64 M $9.68 M $9.70 M $9.49 M $14.99 M $18.13 M
Interest Income $12,000.00 $266,000.00 $210,000.00 $16,000.00 $42,000.00 $224,000.00 $331,000.00 $118,000.00 $37,000.00 $9,000.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $6,000.00 $31,000.00 $32,000.00 $43,000.00 $20,000.00 $20,000.00 $29,000.00 $32,000.00 $133,000.00 $210,000.00
EBITDA -$12.00 M -$25.42 M -$27.62 M -$22.69 M -$10.62 M -$9.66 M -$9.52 M -$9.46 M -$14.02 M -$15.96 M
EBITDA Ratio -279.02 -60.53 0 0 0 0 -63.46 0 -16.63 -8.21
Operating Income Ratio -279.16 -60.6 0 0 0 0 -63.65 0 -16.79 -8.32
Total Other Income/Expenses Net $10,000.00 -$98,000.00 $1.74 M $204,000.00 $955,000.00 $556,000.00 $923,000.00 $1.03 M $376,000.00 -$316,000.00
Income Before Tax -$11.99 M -$25.55 M -$25.92 M -$22.73 M -$9.68 M -$9.13 M -$8.63 M -$8.46 M -$13.77 M -$16.49 M
Income Before Tax Ratio -278.93 -60.84 0 0 0 0 -57.5 0 -16.34 -8.48
Income Tax Expense -$782,000.00 -$3.00 M -$4.72 M -$3.85 M -$1.24 M -$1.30 M -$1.34 M -$993,000.00 -$1.98 M -$2.14 M
Net Income -$11.21 M -$22.56 M -$21.20 M -$18.89 M -$8.45 M -$7.83 M -$7.29 M -$7.47 M -$11.79 M -$14.34 M
Net Income Ratio -260.74 -53.7 0 0 0 0 -48.59 0 -13.99 -7.38
EPS -5.21 -13.255 -14.125 -15.87 -17.43 -19.5 -18.155 -18.61 -516.425 -792.99
EPS Diluted -5.21 -13.255 -14.125 -15.87 -17.43 -19.5 -18.155 -18.61 -516.425 -792.99
Weighted Average Shares Out $5.36 M $1.70 M $1.50 M $1.19 M $484,450.00 $401,414.00 $401,414.00 $401,414.00 $22,832.00 $18,086.00
Weighted Average Shares Out Diluted $5.36 M $1.70 M $1.50 M $1.19 M $484,450.00 $401,414.00 $401,414.00 $401,414.00 $22,832.00 $18,086.00
Link